BR0112603A - Uso de antagonistas receptores de il-8 no tratamento de infecções por vìrus - Google Patents

Uso de antagonistas receptores de il-8 no tratamento de infecções por vìrus

Info

Publication number: BR0112603A
Authority: BR; Brazil
Prior art keywords: treatment; virus infections; receptor antagonists; infections; receptor
Prior art date: 2000-07-18

Application number

BR0112603-2A

Other languages

English (en)

Portuguese (pt)

Inventor

Susan B Dillon

Ruth Tal-Singer

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-18

Filing date

2001-07-16

Publication date

2004-08-24

2001-07-16 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2004-08-24 Publication of BR0112603A publication Critical patent/BR0112603A/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BR0112603-2A 2000-07-18 2001-07-16 Uso de antagonistas receptores de il-8 no tratamento de infecções por vìrus BR0112603A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US21905300P	2000-07-18	2000-07-18
PCT/US2001/022328 WO2002005814A1 (en)	2000-07-18	2001-07-16	Use of il-8 receptor antagonists in the treatment of virus infections

Publications (1)

Publication Number	Publication Date
BR0112603A true BR0112603A (pt)	2004-08-24

Family

ID=22817645

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR0112603-2A BR0112603A (pt)	2000-07-18	2001-07-16	Uso de antagonistas receptores de il-8 no tratamento de infecções por vìrus

Country Status (17)

Country	Link
EP (1)	EP1307190A4 (es)
JP (1)	JP2004509852A (es)
KR (1)	KR20030019587A (es)
CN (1)	CN1449285A (es)
AR (1)	AR033830A1 (es)
AU (1)	AU2001273497A1 (es)
BR (1)	BR0112603A (es)
CA (1)	CA2418162A1 (es)
CZ (1)	CZ2003132A3 (es)
HU (1)	HUP0300754A3 (es)
IL (1)	IL153921A0 (es)
MX (1)	MXPA03000500A (es)
NO (1)	NO20030201L (es)
NZ (1)	NZ523659A (es)
PL (1)	PL365886A1 (es)
WO (1)	WO2002005814A1 (es)
ZA (1)	ZA200300474B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1819329A2 (en) *	2004-08-04	2007-08-22	Schering Corporation	Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
TW201625247A (zh) *	2014-05-12	2016-07-16	葛蘭素史密斯克藍智慧財產權有限公司	用於治療傳染性疾病之醫藥組合物
WO2021191305A1 (en) *	2020-03-26	2021-09-30	Dompe' Farmaceutici Spa	Cxcl8 inhibitors for use in the treatment of covid-19
EP3884932A1 (en) *	2020-03-26	2021-09-29	Dompe' Farmaceutici S.P.A.	Cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) *	2020-12-02	2022-06-08	Dompe' Farmaceutici S.P.A.	Cxcl8 inhibitors for use in the treatment of covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5547979A (en) *	1992-03-30	1996-08-20	Smithkline Beecham	TNF inhibition
WO1996005836A2 (en) *	1994-08-25	1996-02-29	Medical University Of South Carolina	Methods of treating cold symptoms using pentoxifylline
JPH11503110A (ja) *	1995-02-17	1999-03-23	スミスクライン・ビーチャム・コーポレイション	Ｉｌ−８受容体拮抗剤
SE9802729D0 (sv) *	1998-08-13	1998-08-13	Astra Pharma Prod	Novel Compounds
SE9802937D0 (sv) *	1998-09-01	1998-09-01	Astra Pharma Prod	Novel compounds

2001
- 2001-07-16 IL IL15392101A patent/IL153921A0/xx unknown
- 2001-07-16 EP EP01952777A patent/EP1307190A4/en not_active Withdrawn
- 2001-07-16 NZ NZ523659A patent/NZ523659A/en unknown
- 2001-07-16 MX MXPA03000500A patent/MXPA03000500A/es unknown
- 2001-07-16 CA CA002418162A patent/CA2418162A1/en not_active Abandoned
- 2001-07-16 JP JP2002511746A patent/JP2004509852A/ja not_active Withdrawn
- 2001-07-16 WO PCT/US2001/022328 patent/WO2002005814A1/en not_active Ceased
- 2001-07-16 AU AU2001273497A patent/AU2001273497A1/en not_active Abandoned
- 2001-07-16 CZ CZ2003132A patent/CZ2003132A3/cs unknown
- 2001-07-16 KR KR10-2003-7000717A patent/KR20030019587A/ko not_active Withdrawn
- 2001-07-16 PL PL01365886A patent/PL365886A1/xx not_active Application Discontinuation
- 2001-07-16 CN CN01813095A patent/CN1449285A/zh active Pending
- 2001-07-16 BR BR0112603-2A patent/BR0112603A/pt not_active IP Right Cessation
- 2001-07-16 HU HU0300754A patent/HUP0300754A3/hu unknown
- 2001-07-16 AR ARP010103395A patent/AR033830A1/es not_active Application Discontinuation
2003
- 2003-01-15 NO NO20030201A patent/NO20030201L/no not_active Application Discontinuation
- 2003-01-17 ZA ZA200300474A patent/ZA200300474B/en unknown

Also Published As

Publication number	Publication date
PL365886A1 (en)	2005-01-10
NO20030201D0 (no)	2003-01-15
EP1307190A1 (en)	2003-05-07
KR20030019587A (ko)	2003-03-06
AU2001273497A1 (en)	2002-01-30
CN1449285A (zh)	2003-10-15
HUP0300754A3 (en)	2009-03-02
NZ523659A (en)	2006-01-27
IL153921A0 (en)	2003-07-31
CA2418162A1 (en)	2002-01-24
WO2002005814A1 (en)	2002-01-24
MXPA03000500A (es)	2003-06-24
NO20030201L (no)	2003-03-17
EP1307190A4 (en)	2007-08-22
ZA200300474B (en)	2004-08-17
AR033830A1 (es)	2004-01-07
CZ2003132A3 (cs)	2003-09-17
JP2004509852A (ja)	2004-04-02
HUP0300754A2 (hu)	2003-08-28

Publication	Publication Date	Title
BR0111913A (pt)	2004-01-06	Análogos de gabapentina para distúrbios do sono
ES2248356T3 (es)	2006-03-16	Compuestos para tratar la enfermedad de alzheimer.
BRPI0411900A (pt)	2006-09-19	compostos antivirais e métodos
BR0110968A (pt)	2005-05-10	Antagonistas dos receptores de il-8
TR199901710T2 (xx)	1999-09-21	IL-8 resept�r antagonistleri.
TR200102021T2 (tr)	2001-12-21	TWEAK ve TWEAK reseptörü antagonistleri ve bunların imünolojik bozuklukların iyileştirilmesi için kullanımları
BR0014293A (pt)	2002-05-21	Uso de retigabina para o tratamento de dor neuropática
DK1368060T3 (da)	2010-08-30	HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
EA200000911A1 (ru)	2001-04-23	Новые кристаллические формы антивирусного соединения бензимидазола
ATE302005T1 (de)	2005-09-15	N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
EA200201247A1 (ru)	2003-10-30	Соединения для лечения болезни альцгеймера
ATE302606T1 (de)	2005-09-15	N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
BR0211604A (pt)	2004-08-24	Inibidores de integrina para o tratamento de doenças do olho
BRPI0511875A (pt)	2008-01-15	uso de compostos de peptìdeo para tratamento da esclerose lateral amiotrófica
BR0014041A (pt)	2003-07-15	Utilização de csaids em infecção por rinovìrus
DE60121461D1 (de)	2006-08-24	Kondensierte pyridoindolderivate
BR0108866A (pt)	2004-02-25	Antagonistas de receptor de il-8
BR0205812A (pt)	2005-05-03	Benzimidazois úteis no tratamento da disfunção sexual
BR0213684A (pt)	2004-10-26	Uso de antagonistas do receptor de endotelina para o tratamento de doenças tumorìgenas
BR0314844A (pt)	2005-08-09	Novo composto
BR0314843A (pt)	2005-08-09	Novo composto
BR0112603A (pt)	2004-08-24	Uso de antagonistas receptores de il-8 no tratamento de infecções por vìrus
BR9801132A (pt)	2000-03-21	N-heterociclos fundidos, substituìdos com benzilóxi, processo para a sua preparação e seu uso como antagonistas de receptor de bradiquinina.
TR199901761T2 (xx)	1999-10-21	IL-8 resept�r antagonistleri.
BR9815335A (pt)	2000-10-17	Uso de antagonistas de receptor de endotelina.

Legal Events

Date	Code	Title	Description
2010-04-27	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 8A E 9A A NUIDADES.
2011-06-14	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010.